20h
RyCarma announces new leadership and company name. Lead candidate ARM210 to be developed in a new program for heart failure as well as for RYR1-RM.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback